Literature DB >> 7545681

Biosynthesis of GlyCAM-1, a mucin-like ligand for L-selectin.

D Crommie1, S D Rosen.   

Abstract

L-selectin, a member of the selectin family of leukocyte-endothelial adhesion proteins, mediates the initial attachment of lymphocytes to lymph node high endothelial venules during lymphocyte recirculation. One of the endothelial-associated ligands for L-selectin is GlyCAM-1, a mucin-like glycoprotein, which presents novel sulfated, sialylated and fucosylated O-glycans. In order to understand the generation of these glycans, we have examined the biosynthesis of GlyCAM-1 in lymph node organ culture. Using peptide-specific antibodies, lectins, and recombinant L-selectin, we detected the following species of GlyCAM-1: unglycosylated (< 28 kDa); modified with GalNAc only (28-33 kDa); modified with sialic acid, fucose, and sulfate but lacking L-selectin reactivity (40-50 kDa); and mature (L-selectin-reactive) ligand (50-60 kDa). Pulse-chase labeling at 15 degrees C suggested that GalNAc is added in a pre-Golgi compartment. Treatment with brefeldin A almost completely blocked sulfation, indicating that this modification occurs in the trans-Golgi network. Two distinct sialylation events occurred in the presence of brefeldin A, while fucosylation was partially blocked. We conclude that sialylation precedes both fucosylation and sulfation during biosynthesis. This ordering will help to identify the critical acceptor structures recognized by lymph node glycosyltransferases and sulfotransferases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545681     DOI: 10.1074/jbc.270.38.22614

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Characterization of a spleen sulphotransferase responsible for the 6-O-sulphation of the galactose residue in sialyl-N-acetyl-lactosamine sequences.

Authors:  R G Spiro; V D Bhoyroo
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 2.  In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands.

Authors:  R Renkonen; P Mattila; M L Majuri; J Räbinä; S Toppila; J Renkonen; L Hirvas; J Niittymäki; J P Turunen; O Renkonen; T Paavonen
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Characterization of distinct Gal:3-O-sulfotransferase activities in human tumor epithelial cell lines and of calf lymph node GlcNAc : 6-O-sulfotransferase activity.

Authors:  E V Chandrasekaran; R K Jain; J M Rhodes; R Chawda; C Piskorz; K L Matta
Journal:  Glycoconj J       Date:  1999-09       Impact factor: 2.916

4.  Transient Surface CCR5 Expression by Naive CD8+ T Cells within Inflamed Lymph Nodes Is Dependent on High Endothelial Venule Interaction and Augments Th Cell-Dependent Memory Response.

Authors:  David Askew; Charles A Su; Deborah S Barkauskas; R Dixon Dorand; Jay Myers; Rachel Liou; Joseph Nthale; Alex Y Huang
Journal:  J Immunol       Date:  2016-03-18       Impact factor: 5.422

5.  Sialylated, fucosylated ligands for L-selectin expressed on leukocytes mediate tethering and rolling adhesions in physiologic flow conditions.

Authors:  R C Fuhlbrigge; R Alon; K D Puri; J B Lowe; T A Springer
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

6.  Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans.

Authors:  L Giuffrè; A S Cordey; N Monai; Y Tardy; M Schapira; O Spertini
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

7.  Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin.

Authors:  A Bistrup; S Bhakta; J K Lee; Y Y Belov; M D Gunn; F R Zuo; C C Huang; R Kannagi; S D Rosen; S Hemmerich
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

8.  Sex Differences in Mouse Popliteal Lymph Nodes.

Authors:  Riva Dill-Garlow; KuanHui Ethan Chen; Ameae M Walker
Journal:  Sci Rep       Date:  2019-01-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.